Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve the Audited financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Ltd has informed BSE that its Board of Directors will meet on Thursday, May 29, 2025. The key items on the agenda are: (1) to consider and approve the audited financial results for the quarter and financial year ended March 31, 2025, and (2) the induction of a new Women Independent Director, Mrs. Shilpa Bung (DIN: 08257931). The trading window for dealing in the company's securities has been closed since April 1, 2025 and will reopen 48 hours after the financial results are announced.
Investors should watch for the FY25 audited results on May 29, which could drive short-term stock movement. The appointment of a new independent director strengthens board composition but is routine governance housekeeping.